Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.
Cellworks Group operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and biomarker discovery and research in focused therapeutic areas. The company provides disease-focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cells with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and aging; and neurodegenerative.The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2012 | Series B | $13M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sequoia Capital | — | Series B |